Endocrine Abstracts

Introduction: Malnutrition is a common problem amongst patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs). A recent study from our group reported 75% of patients with GEP-NETs treated with monthly somatostatin analogues (SSAs) are malnourished (1). Ideally, all malnourished patients are offered nutritional support. However, guidelines and support are often lacking. The natural course of malnutrition in patients with GEP-NETs is unknown.The aim of t...